Workflow
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
DNAGinkgo Bioworks (DNA) fool.com·2024-05-20 16:40

Is Ginkgo stock a sell? Although possessing enough cash to keep it going for about two years at its current burn rate, I'm just not sure this company is going anywhere fast. To me, that makes Ginkgo stock a sell. Ginkgo Bioworks has become a penny stock -- and that's the least of its problems, Massaro is most concerned with management commentary that new "cell programs" -- of which the company expects to add 100 this year -- are no longer a great forecaster of revenue growth, and may give investors a false ...